Implantable system for stimulating a human heart or an animal heart

Patent metadata

Field	Value
Publication number	US-11628303-B2
Application number	US-202016835628-A
Country	US
Kind code	B2
Filing date	Mar 31, 2020
Priority date	Apr 18, 2019
Publication date	Apr 18, 2023
Grant date	Apr 18, 2023

Abstract

An implantable system for stimulating a human heart or an animal heart contains a processor, a memory unit, an atrial stimulation unit, and a detection unit for detecting atrial tachycardia. The system is characterized in that the memory unit stores a computer-readable program, which prompts the processor to carry out the following steps when the program is being executed on the processor: a) detecting by way of the detection unit whether atrial tachycardia to be treated is present in a human heart or an animal heart; b) when atrial tachycardia to be treated is present, applying atrial antitachycardia pacing by way of the atrial stimulation unit; and c) after the atrial antitachycardia pacing has been applied, carrying out an atrial post-treatment stimulation, the post-treatment stimulation being configured to be within a range of 1 minute up to 7 days.

First claim

The invention claimed is:

1. An implantable system for stimulating a heart including a human heart or an animal heart, the implantable system comprising:
a processor;
an atrial stimulator;
a detector for detecting atrial tachycardia,
a memory storing a computer-readable program prompting said processor to carry out the following steps when the computer-readable program is being executed on said processor:
detecting by way of said detector whether the atrial tachycardia to be treated is present in the human heart or the animal heart;
applying atrial antitachycardia pacing by way of the atrial stimulator when the atrial tachycardia to be treated is present; and
carrying out an atrial post-treatment stimulation after the atrial antitachycardia pacing has been applied only when no tachycardiac intrinsic atrial activity is present, wherein the atrial post-treatment stimulation is applied with the atrial stimulator and is configured to be within a range of 1 minute up to 7 days, and the atrial post-treatment stimulation uses a stimulation rate of less or equal to 200 bpm.

2. The implantable system according to claim 1 , wherein the computer-readable program prompts said processor, after the atrial antitachycardia pacing has been applied, to initially check by way of said detector whether the atrial tachycardia has been terminated, and to carry out the atrial post-treatment stimulation only when a termination of the atrial tachycardia has been established.

3. The implantable system according to claim 1 , wherein the computer-readable program prompts said processor to carry out the atrial post-treatment stimulation in a form of right atrial overdrive pacing.

4. The implantable system according to claim 1 , wherein the computer-readable program prompts said processor to carry out the atrial post-treatment stimulation in a form of left atrial overdrive pacing.

5. The implantable system according to claim 1 , wherein the computer-readable program prompts said processor to carry out the atrial post-treatment stimulation in a form of biatrial overdrive pacing.

6. The implantable system according to claim 1 , wherein the computer-readable program prompts said processor to carry out the atrial post-treatment stimulation during a first duration.

7. The implantable system according to claim 1 , wherein the computer-readable program prompts said processor to carry out the atrial post-treatment stimulation during a defined number of cardiac cycles.

8. The implantable system according to claim 1 , wherein the computer-readable program prompts said processor to carry out the atrial post-treatment stimulation so that a pressure in a left and/or right atrium is lowered at least briefly, a risk of mitral valve regurgitation is reduced at least briefly or entirely avoided, a preload of the heart is reduced at least briefly, a blood pressure of a patient whose said heart is being stimulated by the implantable system is lowered at least briefly, and/or a myocardial oxygen balance is improved at least briefly, by setting an AV delay ascertained as being optimal and/or biventricular pacing and/or an increased ventricular pacing rate for the patient.

9. The implantable system according to claim 1 , wherein said atrial stimulator is configured to apply the atrial antitachycardia pacing and/or the atrial post-treatment stimulation in a form of electrical stimulation or in a form of optical stimulation.

10. The implantable system according to claim 1 , wherein the computer-readable program prompts said processor to deliver the atrial post-treatment stimulation using a stimulation rate of less than or equal to 180 bpm.

11. The implantable system according to claim 1 , wherein the computer-readable program prompts said processor to deliver the atrial post-treatment stimulation using a stimulation rate of less than or equal to 150 bpm.

12. The implantable system according to claim 1 , wherein the computer-readable program prompts said processor to deliver the atrial post-treatment stimulation using a stimulation rate of less than or equal to 140 bpm.

13. The implantable system according to claim 1 , wherein the computer-readable program prompts said processor to deliver the atrial post-treatment stimulation using a stimulation rate of less than or equal to 130 bpm.

14. The implantable system according to claim 1 , wherein the computer-readable program prompts said processor to deliver the atrial post-treatment stimulation using a stimulation rate of less than or equal to 100 bpm.

15. A method for treating a patient, including a human patient or an animal patient, requiring such treatment by way of an implantable system for stimulating a heart of the patient, the implantable system containing a processor, a memory, an atrial stimulator, and a detector for detecting atrial tachycardia, which method comprises the following steps of:
detecting by way of the detector whether the atrial tachycardia to be treated is present in the heart of the patient;
applying atrial antitachycardia pacing by way of the atrial stimulator when the atrial tachycardia to be treated is present; and
carrying out an atrial post-treatment stimulation after the atrial antitachycardia pacing has been applied only when no tachycardiac intrinsic atrial activity is present, wherein the post-treatment stimulation is applied with the atrial stimulator and is configured to be within a range of 1 minute up to 7 days, and the post-treatment stimulation uses a stimulation rate of less or equal to 200 bpm.

16. The method according to claim 15 , wherein the step of carrying out the atrial post-treatment stimulation is only performed when the atrial intrinsic heart rhythm is less than 100 bpm.

17. The implantable system according to claim 1 , wherein the step of carrying out the atrial post-treatment stimulation is only performed when the atrial intrinsic heart rhythm is less than 100 bpm.

Assignees

• Biotronik Se & Co Kg

Inventors

• Doerr Thomas
• Ershov Sergey
• Radtke Torsten
• Roemer Martin
• Weiss Ingo

Classifications

• G16H40/67

  for remote operation · CPC title

• A61B5/363

  Detecting tachycardia or bradycardia · CPC title

• A61N1/3688

  configured for switching the pacing mode, e.g. from AAI to DDD · CPC title

• A61N1/36842

  Multi-site stimulation in the same chamber · CPC title

• A61N1/3624 Primary

  occurring in the atrium, i.e. atrial tachycardia · CPC title